CLDX vs SO · rev $7.0M vs P/E 22, rev $29.55B
Celldex Therapeutics Inc (CLDX) versus Southern Company (SO) — a side-by-side from cached financials, not a winner call.
Celldex Therapeutics Inc (CLDX) is a biotechnology company listed on US.
Southern Company (SO) is a utilities - regulated electric company listed on US.
Latest reported CLDX revenue for 2024-12-31 was $7.0M. Revenue was up 2.0% from 2023-12-31 to 2024-12-31. CLDX currently screens at market cap $2.35B.
Latest reported SO revenue for 2025-12-31 was $29.55B. Net income was $4.34B. Revenue was up 10.6% from 2024-12-31 to 2025-12-31. SO currently screens at market cap $101.55B and trailing P/E 22.1.
CLDX currently screens at market cap $2.35B. SO currently screens at market cap $101.55B and trailing P/E 22.1.
Not investment advice. Open the CLDX and SO stock pages for the full models.
Not investment advice.